Paul Gurbel to Drug-Eluting Stents
This is a "connection" page, showing publications Paul Gurbel has written about Drug-Eluting Stents.
Connection Strength
0.207
-
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study. JACC Cardiovasc Interv. 2017 08 28; 10(16):1607-1617.
Score: 0.108
-
Immunity to thrombotic events is achievable if we stop the guessing game: is this the major hidden message from GRAVITAS? Thromb Haemost. 2011 Aug; 106(2):263-4.
Score: 0.070
-
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Circ Cardiovasc Interv. 2018 10; 11(10):e006853.
Score: 0.029